Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
42
CPRX
Catalyst Pharmaceuticals
Last Price:
21.34
Seasonality Move:
-9.09%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Catalyst Pharmaceuticals Price Quote
$21.34
+0.91 (+4.45%)
(Updated: September 19, 2024 at 6:55 PM ET)
Catalyst Pharmaceuticals Key Stats
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Day range:
$20.15 - $20.79
52-week range:
$11.55 - $20.87
Dividend yield:
0%
P/E ratio:
32.43
P/S ratio:
5.51
P/B ratio:
3.98%
Volume:
648.5K
Avg. volume:
1.1M
1-year change:
61.89%
Market cap:
$2.4B
Revenue:
$398.2M
EPS:
$0.54
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $398.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $71.4M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.23% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went up by 2.82% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price rose by 61.89% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $20.87 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $11.55 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 20.81 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 17.82 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.00 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 23.86
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $375.7M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.14
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $196.8M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $131.4M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$131.3M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 14.93% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 12.71% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 14.93%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 20.43 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on November 8, 2024 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
-
What Is CPRX Dividend Yield?
Catalyst Pharmaceuticals’s dividend yield currently is 0% -
What Is Catalyst Pharmaceuticals’s Payout Ratio?
Catalyst Pharmaceuticals’s payout ratio is 0% -
When Did Catalyst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Catalyst Pharmaceuticals’s Dividend Per Share?
Catalyst Pharmaceuticals pays a dividend of $0.00 per share
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 31.45% |
| Revenue: | 23.23% | 9.69% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 30.14 |
| Upside from Last Price: | 47.54% |